Keyphrases
Zoledronic Acid
100%
Breast Cancer
100%
Recurrent Disease
28%
Metastatic Breast Cancer
28%
Bone Metastasis
14%
Clinical Outcomes
14%
Bisphosphonates
14%
Chemotherapy
14%
Bone Loss
14%
Bone Resorption
14%
Neoadjuvant Therapy
14%
Phase II Trial
14%
Disease Pattern
14%
Pharmacodynamics
14%
Efficacy Data
14%
Dose Rate
14%
Dosing Regimen
14%
Safety Data
14%
Tumor Burden
14%
Intermediate Risk
14%
Early Breast Cancer
14%
Monthly Dosing
14%
Bone Tumor
14%
Therapeutic Goals
14%
Ongoing Clinical Trials
14%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Zoledronic Acid
100%
Recurrent Disease
28%
Metastatic Breast Cancer
28%
Bone Metastasis
14%
Neoplasm
14%
Clinical Trial
14%
Disease
14%
Bisphosphonic Acid Derivative
14%
Pharmacodynamics
14%
Chemotherapy
14%